Lead Pharma is a renowned brand that specializes in developing innovative small-molecule therapies for patients with autoimmune disease or cancer. As a spinoff from the prestigious Hubrecht Institute and the University Medical Center Utrecht, Lead Pharma is backed by cutting-edge scientific research and expertise. Headquartered at Pivot Park in Oss, the Netherlands, Lead Pharma operates from a state-of-the-art biopharmaceutical life sciences campus.

Their fully equipped labs enable them to carry out every stage of drug discovery, including medicinal chemistry, cellular pharmacology, molecular pharmacology, and in silico research. Additionally, Lead Pharma collaborates with specialized contract research organizations for in vivo pharmacology and toxicology studies. With a qualified team of 29 employees, including 10 individuals with a PhD degree, Lead Pharma combines deep industry knowledge and academic insights.

Their success stems from a combination of high quality standards, effective teamwork, and an environment that fosters agility, creativity, inspiration, and passion. Lead Pharma is dedicated to transforming the lives of patients through groundbreaking therapies, driven by their commitment to scientific excellence and innovation